A Langslet

916 total citations
37 papers, 719 citations indexed

About

A Langslet is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A Langslet has authored 37 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A Langslet's work include Cardiac electrophysiology and arrhythmias (9 papers), Receptor Mechanisms and Signaling (5 papers) and Pharmaceutical studies and practices (4 papers). A Langslet is often cited by papers focused on Cardiac electrophysiology and arrhythmias (9 papers), Receptor Mechanisms and Signaling (5 papers) and Pharmaceutical studies and practices (4 papers). A Langslet collaborates with scholars based in Norway, Denmark and Argentina. A Langslet's co-authors include Ivar Øye, Alf Meberg, Rolf Lindemann, J. E. Bredesen, P. K. M. Lunde, Knut Liestøl, Ingebjørg Buajordet, Torvid Kiserud, Ingar Olsen and P Løkken and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Heart.

In The Last Decade

A Langslet

36 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Langslet Norway 16 219 205 152 95 73 37 719
M. L. Mashford Australia 16 132 0.6× 173 0.8× 169 1.1× 42 0.4× 163 2.2× 39 867
Yuichi Koike Japan 15 141 0.6× 116 0.6× 74 0.5× 54 0.6× 49 0.7× 48 628
Brian L. Lloyd Australia 13 173 0.8× 260 1.3× 39 0.3× 59 0.6× 60 0.8× 36 705
R. F. W. Moulds Australia 15 251 1.1× 231 1.1× 39 0.3× 73 0.8× 104 1.4× 44 786
M S Yates United Kingdom 16 201 0.9× 112 0.5× 59 0.4× 83 0.9× 48 0.7× 56 898
Guillermo Di Girolamo Argentina 22 237 1.1× 241 1.2× 170 1.1× 59 0.6× 53 0.7× 107 1.3k
C. W. H. Havard United Kingdom 21 150 0.7× 161 0.8× 75 0.5× 109 1.1× 86 1.2× 99 1.5k
P J Pentikäinen Finland 14 90 0.4× 220 1.1× 47 0.3× 44 0.5× 58 0.8× 32 790
M. J. WATSON United Kingdom 18 139 0.6× 66 0.3× 62 0.4× 77 0.8× 51 0.7× 41 899
Jordan E. Roberts United States 17 217 1.0× 225 1.1× 51 0.3× 42 0.4× 101 1.4× 53 736

Countries citing papers authored by A Langslet

Since Specialization
Citations

This map shows the geographic impact of A Langslet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Langslet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Langslet more than expected).

Fields of papers citing papers by A Langslet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Langslet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Langslet. The network helps show where A Langslet may publish in the future.

Co-authorship network of co-authors of A Langslet

This figure shows the co-authorship network connecting the top 25 collaborators of A Langslet. A scholar is included among the top collaborators of A Langslet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Langslet. A Langslet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buajordet, Ingebjørg, Finn Wesenberg, Odd Brørs, & A Langslet. (2002). Adverse drug events in children during hospitalization and after discharge in a Norwegian University Hospital. Acta Paediatrica. 91(1). 88–94. 36 indexed citations
2.
Langslet, A, et al.. (2000). Differential recruitment of α1‐ and β‐adrenoceptors in inotropic control of atrial child myocardium by endogenous noradrenaline. Acta Physiologica Scandinavica. 170(1). 21–31. 3 indexed citations
3.
Fugelseth, Drude, Torvid Kiserud, Knut Liestøl, A Langslet, & Rolf Lindemann. (1999). Ductus venosus blood velocity in persistent pulmonary hypertension of the newborn. Archives of Disease in Childhood Fetal & Neonatal. 81(1). F35–F39. 14 indexed citations
4.
Fugelseth, Drude, Torvid Kiserud, Knut Liestøl, A Langslet, & Rolf Lindemann. (1999). Ductus Venosus Blood Velocity in Persistent Pulmonary Hypertension of the Newborn. Pediatric Research. 45(6). 902–902. 2 indexed citations
5.
Fugelseth, Drude, Rolf Lindemann, Knut Liestøl, Torvid Kiserud, & A Langslet. (1998). Postnatal closure of ductus venosus in preterm infants ≤32 weeks. Early Human Development. 53(2). 163–169. 28 indexed citations
6.
Fugelseth, Drude, Rolf Lindemann, Knut Liestøl, Torvid Kiserud, & A Langslet. (1997). Ultrasonographic study of ductus venosus in healthy neonates. Archives of Disease in Childhood Fetal & Neonatal. 77(2). F131–F134. 42 indexed citations
7.
Hågå, P, et al.. (1995). Endogenous norepinephrine stimulates both α1- and β-adrenoceptors in myocardium from children with congenital heart defects. Journal of Molecular and Cellular Cardiology. 27(1). 693–699. 9 indexed citations
8.
Hågå, P, et al.. (1994). Functional Characterization of an Ex Vivo Preparation of Atrial Myocardium from Children with Congenital Heart Defects. Journal of Cardiovascular Pharmacology. 24(3). 365–371. 8 indexed citations
9.
Hågå, P, et al.. (1994). 26 ADDRENERGIC α-RECEPTORS IN THE HEART: DO THEY MATTER?. Pediatric Research. 36(1). 7A–7A. 1 indexed citations
10.
Skjørten, F, et al.. (1993). Possible X linked congenital mitochondrial cardiomyopathy in three families.. Journal of Medical Genetics. 30(4). 269–272. 17 indexed citations
11.
Skomedal, Tor, Halfdan Aass, Jan‐Bjørn Osnes, et al.. (1985). Demonstration of an α-adrenergic inotropic effect (α-aIE) of noradrenaline (NA) in human myocardium. Journal of Molecular and Cellular Cardiology. 17. 39–39. 1 indexed citations
12.
Skomedal, Tor, Halfdan Aass, Jan‐Bjørn Osnes, et al.. (1985). Demonstration of an alpha adrenoceptor-mediated inotropic effect of norepinephrine in human atria.. Journal of Pharmacology and Experimental Therapeutics. 233(2). 441–446. 41 indexed citations
13.
Langslet, A, et al.. (1982). AUDITORY BRAINSTEM RESPONSES (ABR) IN HIGH‐RISK NEONATES. Acta Paediatrica. 71(5). 711–715. 26 indexed citations
14.
Saugstad, Ola Didrik, et al.. (1982). ACTIVATION OF THE KALLIKREIN‐KININ SYSTEM IN PREMATURE INFANTS WITH RESPIRATORY DISTRESS SYNDROME (RDS). Acta Paediatrica. 71(6). 965–968. 9 indexed citations
15.
Langslet, A, et al.. (1972). The role of cyclic AMP in the inotropic response to isoprenaline and glucagon.. PubMed. 1. 291–300. 13 indexed citations
16.
Langslet, A. (1971). Effects of phenothiazines on the release of aspartate aminotransferase from hypothermic asystolic hearts subjected to hypoxia. European Journal of Pharmacology. 13(3). 292–294. 4 indexed citations
17.
Langslet, A & Morten Ryg. (1971). Effects of Chlorpromazine and Propranolol on Left Ventricular Systolic Pressure, ECG, and K+Efflux in the Isolated Perfused Rat Heart. Acta Pharmacologica et Toxicologica. 29(5-6). 533–541. 4 indexed citations
18.
19.
Langslet, A. (1970). Membrane stabilization and cardiac effects of d,1-propranolol, d-propranolol and chlorpromazine. European Journal of Pharmacology. 13(1). 6–14. 72 indexed citations
20.
Langslet, A. (1970). ECG‐Changes Induced by Phenothiazine Drugs in the Anaesthetized Rat. Acta Pharmacologica et Toxicologica. 28(4). 258–264. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. L. Mashford Breakdown of academic impact, for papers by Yuichi Koike Breakdown of academic impact, for papers by Brian L. Lloyd Breakdown of academic impact, for papers by R. F. W. Moulds Breakdown of academic impact, for papers by M S Yates Breakdown of academic impact, for papers by Guillermo Di Girolamo Breakdown of academic impact, for papers by C. W. H. Havard Breakdown of academic impact, for papers by P J Pentikäinen Breakdown of academic impact, for papers by M. J. WATSON Breakdown of academic impact, for papers by Jordan E. Roberts
Rankless by CCL
2026